Coronavirus: older persons with cancer in Italy in the COVID-19 pandemic
Open accessAbstract
Italy is the European country that was hit first and hardest by the COVID-19 epidemic. Since February 2020, the outbreak of the epidemic disease in Italy, with fatal outcomes in up to 10% of cases, made it urgent to implement extraordinary measures to avoid a breakdown of the universal Italian national health system. The update for April 1, 2020, in Italy recorded 102,669 confirmed COVID-19 cases, with a median patient age of 63 years. The deceased patients were older people (median age 80 years) and often had a cancer diagnosis (about 20%). Thus, in the extraordinary epidemiological scenario of the COVID-19 pandemic in Italy, older persons in cancer treatment are at particularly high risk of being severely affected by COVID-19. These people face a health- and economics-related emergency that also carries cultural and ethical implications. In accordance with the measures adopted by the Italian government to limit viral transmission, several associations of Italian oncologists have taken action to update Elderly Cancer Care programs. In view of the newly emerging needs, we herein outline practical suggestions aimed at guaranteeing the best continuity to elderly cancer patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Among patients with thoracic malignancies and COVID-19 in the TERAVOLT cohort, being 65 years or older was linked to a higher risk of death (OR 1.88, 95% CI 1.0-3.6).
“In the TERAVOLT cohort of patients with thoracic malignancies and COVID-19, age was also closely associated with increased risk of death, with patients aged 65 years and older (OR 1.88, 95% CI 1.0–3.6) [15].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016 · see citing works
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384 · see citing works
COVID-19 and Italy: what next?
Remuzzi, A., & Remuzzi, G. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30627-9 · Cited by 3,119 · see citing works
Repetto, L., Fratino, L., Audisio, R. A., Venturino, A., Gianni, W., Vercelli, M., Parodi, S., Lago, D. D., Gioia, F., Monfardini, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.494 · Cited by 912 · see citing works
Self-citationRepetto, L., Fratino, L., Audisio, R. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.2.494 · Cited by 551 · see citing works
Self-citationMicrovessel density is a prognostic indicator for patients with astroglial brain tumors
Leon, S. P., Folkerth, R. D., & Black, P. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2 · Cited by 477 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Saini, K. S., Tagliamento, M., Lambertini, M., McNally, R., Romano, M., Leone, M., Curigliano, G., & de Azambuja, E. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.011 · Cited by 332 · see citing works
A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus
Venkatesulu, B. P., Chandrasekar, V. T., Girdhar, P., Advani, P. G., Sharma, A., Elumalai, T., Hsieh, R. C.-E., Elghazawy, H. I., Verma, V., & Krishnan, S. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa102 · Cited by 149 · see citing works
Kaspar, K. (2020) · Journal of Medical Internet Research · doi:10.2196/21613 · Cited by 117 · see citing works
Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
Behl, T., Sharma, A., Sharma, L. K., Sehgal, A., Zengin, G., Brata, R. D., Frățilă, O., & BUNGAU, S. G. (2020) · Biomedicines · doi:10.3390/biomedicines8120571 · Cited by 100 · see citing works
Khoury, E. G., Nevitt, S. J., Madsen, W. R., Turtle, L. C. W., Davies, G., & Palmieri, C. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.10880 · Cited by 85 · see citing works
Battisti, N. M. L., Mislang, A. R., Cooper, L., O'Donovan, A., Audisio, R. A., Cheung, K.-L., Sarrió, R. G., Stauder, R., Soto-Perez-de-Celis, E., Jaklitsch, M., et al. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.07.008 · Cited by 79 · see citing works
Withaferin A: a potential therapeutic agent against COVID-19 infection
Straughn, A. R., & Kakar, S. S. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00684-x · Cited by 70 · see citing works
Madan, A., Siglin, J., & Khan, A. I. (2020) · Cancer Medicine · doi:10.1002/cam4.3534 · Cited by 60 · see citing works
Johannesen, T. B., Smeland, S., Aaserud, S., Buanes, E. A., Skog, A., Ursin, G., & Helland, Å. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.652535 · Cited by 55 · see citing works
Thompson, D. D. P., & ANDERSON, R. (2021) · Journal of Humanitarian Logistics and Supply Chain Management · doi:10.1108/jhlscm-01-2021-0006 · Cited by 46 · see citing works
Ng, S. S. W., Ning, M. S., Lee, P. P., McMahon, R. A., Siva, S., & Chuong, M. D. (2020) · Advances in Radiation Oncology · doi:10.1016/j.adro.2020.06.011 · Cited by 38 · see citing works
First Wave of COVID-19 Pandemic in Italy: Data and Evidence
Bezzini, D., Schiavetti, I., Manacorda, T., Franzone, G., & Battaglia, M. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-85113-2_6 · Cited by 35 · see citing works
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
Calles, A., Aparicio, I., Alva, M., Beranek, M. B., Gutiérrez, N., Soto, J. A., Arregui, M., Tirado, V. C., Álvarez, E. L., del Monte-Millán, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01777 · Cited by 34 · see citing works
SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
Seth, G., Sethi, S., Bhattarai, S., Saini, G., Singh, C. B., & Aneja, R. (2020) · Cancers · doi:10.3390/cancers12113266 · Cited by 32 · see citing works
Bilgili, F., Dündar, M., Kuşkaya, S., Balsalobre‐Lorente, D., Ünlü, F., Gençoğlu, P., & Muğaloğlu, E. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.632192 · Cited by 28 · see citing works
Ning, M. S., McAleer, M. F., Jeter, M. D., Minsky, B. D., Ghafar, R. A., Robinson, I. J., Nitsch, P. L., Zaebst, D. J., Todd, S. E., Nguyen, J. L., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.05.037 · Cited by 28 · see citing works
Lugli, G., Ottaviani, M. M., Botta, A., Ascione, G., Bruschi, A., Cagnazzo, F., Zammarchi, L., Romagnani, P., & Portaluri, T. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.012 · Cited by 27 · see citing works
Prediction Models for COVID-19 Integrating Age Groups, Gender, and Underlying Conditions
Ashraf, I., Alnumay, W. S., Ali, R., Hur, S., Bashir, A. K., & Zikria, Y. B. (2021) · Computers, materials & continua/Computers, materials & continua (Print) · doi:10.32604/cmc.2021.015140 · Cited by 21 · see citing works
Older people at the beginning of the COVID-19 pandemic: A scoping review
Gaertner, B., Fuchs, J., Mohler, R. A., Meyer, G., & Scheidt‐Nave, C. (2021) · PubMed Central · doi:10.25646/7857 · Cited by 20 · see citing works
Serraino, D., Zucchetto, A., Maso, L. D., Zotto, S. D., Taboga, F., Clagnan, E., Fratino, L., Tosolini, F., & Burba, I. (2021) · Cancer Medicine · doi:10.1002/cam4.4271 · Cited by 15 · see citing works
Self-citationGremke, N., Griewing, S., Bausch, E., Alymova, S., Wagner, U. A. G., Kostev, K., & Kalder, M. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05065-7 · Cited by 8 · see citing works
The Effects of Sex Hormones and some Respiratory Diseases on the Severity of Corona Virus Infection
Al-Kurdy, M. J. J., Abbas, G. A., & Kazaal, M. A. (2022) · Bionatura · doi:10.21931/rb/2022.07.02.13 · Cited by 5 · see citing works
Carvalho, M. I., Teles, H. M. M., Ribeirinho, C., & Marques, E. J. D. S. T. (2022) · International Social Work · doi:10.1177/00208728211058775 · Cited by 4 · see citing works
Tang, P.-F., Bao, S.-S., Xie, W., Xiao, Z.-X., Wu, X.-M., & Ge, H.-L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1570206 · Cited by 1 · see citing works
Treating Gastrointestinal Cancer During the Coronavirus Disease 2019 Pandemic in Europe
Collienne, M., & Arnold, D. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.07.004 · Cited by 1 · see citing works
Cancer management during COVID-19 period-A preliminary study
Sundararajan, R. (2020) · The Gazette of Medical Sciences · doi:10.46766/thegms.oncol.20122003
Fratino, L., & Serraino, D. (2021) · Annals of Research in Oncology · doi:10.48286/aro.2021.12
Self-citationSiregar, K. B., Azrah, A., & Aryanti, C. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9116
- Authors
- Fratino, L., Procopio, G., Di Maio, M., Cinieri, S., Leo, S., & Beretta, G.
- Affiliations
- Centro di Riferimento Oncologico (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Ospedale A. Perrino (IT)
- Ospedale Vito Fazzi (IT)
- Humanitas Gavazzeni (IT)
- Corresponding author
- Fratino, Lucia
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-30
- Volume
- 10
- Pages
- 648-648
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC7203468
- OpenAlex
- W3016518525
- Cited by
- 28
- References
- 5
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 5 · 2021: 9 · 2020: 12
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministero della Salute
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, older adults, cancer patients, Italy, pandemic response, health system crisis, ethical implications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
